Yang Yang, Zhaoqing Fan, Yingjian He, Tao Ouyang. "Updated overall survival results from a randomized phase III trial of non–cross-resistant adjuvant chemotherapy plus endocrine therapy versus endocrine therapy alone in HR+/HER2−/lymph node–positive breast cancer with residual disease following neoadjuvant chemotherapy (NCT01019616).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.506